Nebraska Oncology Society 23rd Annual Midwest Regional ASCO Review 2022

Nebraska Oncology Society 23rd Annual Midwest Regional ASCO Review 2022

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

Nebraska Oncology Society 23rd Annual Midwest Regional ASCO Review 2022

Format: 15 videos + 1 pdf, size: 1.33 GB

Course Audience: oncologist

Overview:

No information

 

 

asco_agenda_2022-website (PDF Format)

Early Stage NSCLC Reported and Ongoing Phase 3 Neoadjuvant Chemo and or IO Trials (Video TS Format)

Head and Neck Cancer Update (Video TS Format)

HR Breast Cancer Updates (Video TS Format)

Immunotherapy Updates in Advanced NSCLC (Video TS Format)

Locally Advanced NSCLC (Video TS Format)

Moving Toward a Cure in Myeloma The Role of MRD Testing (Video TS Format)

Phase 3 DESTINY-Breast 03 Trial HER2+ BC Updates (Video TS Format)

Phase 3 KEYNOTE-522 Trial TNBC Updates (Video TS Format)

SCLC Updates IO+Chemo Combinations Remain the Standard of Care (Video TS Format)

Surgically Resectable NSCLC Updates From the Adjuvant IO Trials (Video TS Format)

Updates on Colon Cancer Treatment (Video TS Format)

Updates on GI Cancers Pancreatic, Gastric, Bile Duct, and Neuroendocrine (Video TS Format)

Updates on Molecular Based Imaging for Prostate Cancer Redefining the Disease Landscape (Video TS Format)

Updates on RAS BRAF KRAS NRAS Wild-Type mCRC Summary of Recent Trials (Video TS Format)

Updates on Rectal Cancer Treatment (Video TS Format)